ClinicalTrials.Veeva

Menu

Intranasal Ketamine Versus Intramuscular Ketamine for Procedural Sedation in Pediatric Patients

University of Iowa logo

University of Iowa

Status

Terminated

Conditions

Sedation

Treatments

Drug: Ketamine

Study type

Interventional

Funder types

Other

Identifiers

NCT01170247
201006786
University of Iowa

Details and patient eligibility

About

The purpose of this study is to determine if intranasal ketamine is equally as effective and safe as intramuscular ketamine for procedural sedation in pediatric patients.

Enrollment

3 patients

Sex

All

Ages

2 to 17 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • pediatric patients age 2 to 17 years old
  • have a laceration of 4 cm on the face or 7 cm on the remainder of the body
  • Require procedural sedation to repair the laceration

Exclusion criteria

  • Patients with abnormal nasal physiology which would not allow for adequate medication delivery
  • Unable to have a guardian present to consent on their behalf
  • Allergy to ketamine
  • Significant cardiac history (myocardial ischemia, heart failure, arrhythmias)
  • Presenting with a head injury associated with possible intracranial hypertension
  • Pregnancy
  • Lacerations that require repair from a consult service

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

3 participants in 2 patient groups

Intranasal Ketamine
Experimental group
Treatment:
Drug: Ketamine
Drug: Ketamine
Intramuscular Ketamine
Active Comparator group
Treatment:
Drug: Ketamine
Drug: Ketamine

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems